Trademarkia Logo

Canada

C$
Trademark Search in Canada
TRANSCON

View On IC.GC.CA

TRANSCON
REGISTERED

on 13 Nov 2019

Last Applicant/ Owned by

ASCENDIS PHARMA A/S

Tuborg Boulevard 52900 Hellerup

DK

Serial Number

1849180 filed on 25th Jul 2017

Registration Number

TMA1062896 registered on 13th Nov 2019

Registration expiry Date

13th Nov 2029

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

TRANSCON

Trademark usage description

pharmaceutical and veterinary preparations, including for physical and mental illness, namely, pharmaceutical preparations for the prevention and trea Read More

Classification Information

Class [005]
Pharmaceutical and veterinary preparations, including for physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, namely growth and thyroid disorder, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders, namely, intestinal infectious diseases, infections with a predominantly sexual mode of transmission, viral infections of the central nervous system, arthropod-borne viral fevers and viral haemorrhagic fevers, viral infections characterized by skin and mucous membrane lesions, human immunodeficiency virus [HIV] disease, mycoses, protozoal diseases, and helminthiases, enzyme replacement therapy, anti-inflammatory disease, the relief of pain, the treatment of chronic pain, the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries, respiratory system disorders, autoimmune disorders, vaccines for human and veterinary use; human and veterinary vaccine preparations, human and veterinary vaccines, non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, and multiple sclerosis, bone diseases, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous systems movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, and brain movement diseases, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy, cachexia, metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement ; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes; dietetic substances adapted for medical use, namely, dietetic sugar substitutes adapted for medical use; all-purpose disinfectants for sanitary purposes; fungicides; herbicides

Classification kind code

11

Class [042]
Scientific research within the medical, pharmaceutical and bacteriological area, including consultancy and information relating thereto; conducting of tests regarding medical applications; packaging design for pharmaceutical preparations; designing and development of medical equipment; designing pharmaceutical and medical preparations; preparation of pharmaceutical formulations; design and development of granulation technology and tablet technology, including consultancy and information relating thereto

Classification kind code

11

Class [045]
Licensing of industrial property; legal services

Classification kind code

11

Mark Details

Serial Number

1849180

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 9th Oct 2019		Registration Pending
Submitted for opposition 67
on 11th Sept 2019		Agent Name Changed
Submitted for opposition 42
on 17th Jul 2019		Advertised
Submitted for opposition 26
on 27th Jun 2019		Approved
Submitted for opposition 27
on 8th May 2019		Approval Notice Sent
Submitted for opposition 22
on 6th Jul 2018		Search Recorded
Submitted for opposition 20
on 6th Jul 2018		Examiner's First Report
Submitted for opposition 31
on 1st Aug 2017		Formalized
Submitted for opposition 1
on 26th Jul 2017		Created
Submitted for opposition 30
on 25th Jul 2017		Filed